Under this exclusive agreement, Selista will serve as the sole distributor of Divergence’s neurofeedback technology in Japan. Together, we aim to improve mental health and wellness in this important market, with the goal of making neurofeedback more accessible to practitioners and patients alike.

Alex Ni, Co-founder and CEO of Divergence, commented on the partnership: “Collaborating with Selista is an important step in making remote neurofeedback more accessible and impactful. Japan places a high value on innovation and well-being, and by combining our advanced technology with Selista’s local expertise, we aim to equip clinicians and coaches in Japan with a powerful, cost-effective tool to support mental health. At Divergence, we believe in the transformative potential of neurofeedback and biofeedback, and this partnership reinforces our commitment to improving the lives of everyone around the world through innovative solutions. We look forward to working with Selista to expand the reach of our technology and help practitioners create positive, lasting changes for their patients.”

With Selista’s deep local expertise and Divergence’s cutting-edge technology, we look forward to introducing this solution to a wider audience.
Selista’s President, Yoshi Itoh, added, “At Selista, we are always seeking ways to enhance health and well-being. By partnering with Divergence, we are bringing their advanced neurofeedback technology to Japan, expanding our portfolio of innovative products that support both mental and physical wellness. Divergence’s remote neurofeedback system is an ideal fit with our goal of offering effective and reliable solutions for health professionals. We are confident that this collaboration will empower clinicians and coaches across Japan to provide personalized, impactful care that will benefit many.”

Stay tuned for further updates as we continue to grow our presence in Japan!